MyAverix Finance
NS · Healthcare
Coral Laboratories Ltd (524506)
Pharmaceuticals & Biotechnology
Coral Laboratories Ltd (524506) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.29B, P/E ratio is 13.96, net margin is 18.0%, dividend yield is 0.23%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 524506
Coral Laboratories Ltd (524506) — FAQ
What is Coral Laboratories Ltd's market cap?
Coral Laboratories Ltd (524506) has a reported market cap of $2.29B (data as of 2026-07-10).
What is 524506's P/E ratio?
The price-to-earnings (P/E) ratio for Coral Laboratories Ltd (524506) is 13.96 (data as of 2026-07-10).
Does Coral Laboratories Ltd pay a dividend?
Coral Laboratories Ltd (524506) shows a reported dividend yield of 0.23%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Coral Laboratories Ltd in?
Coral Laboratories Ltd (524506) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 524506 listed on?
524506 is listed on NS.
What is Coral Laboratories Ltd's net margin?
Coral Laboratories Ltd (524506) reports a net margin of 18.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.